Schonfeld Strategic Advisors’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.06M Sell
42,259
-23,592
-36% -$1.15M 0.01% 887
2025
Q1
$3.36M Sell
65,851
-56,429
-46% -$2.88M 0.02% 599
2024
Q4
$5.52M Sell
122,280
-66,953
-35% -$3.02M 0.03% 439
2024
Q3
$7.02M Buy
189,233
+161,572
+584% +$5.99M 0.05% 337
2024
Q2
$846K Buy
+27,661
New +$846K 0.01% 1160
2022
Q4
Sell
-5,745
Closed -$289K 2817
2022
Q3
$289K Sell
5,745
-32,025
-85% -$1.61M ﹤0.01% 2070
2022
Q2
$1.51M Buy
+37,770
New +$1.51M 0.01% 776
2021
Q3
Sell
-60,100
Closed -$2.54M 2245
2021
Q2
$2.54M Buy
+60,100
New +$2.54M 0.03% 613
2020
Q2
Sell
-8,278
Closed -$369K 1462
2020
Q1
$369K Buy
+8,278
New +$369K 0.02% 674
2019
Q3
Sell
-9,600
Closed -$432K 1177
2019
Q2
$432K Buy
+9,600
New +$432K 0.02% 673
2019
Q1
Sell
-31,400
Closed -$1.08M 1186
2018
Q4
$1.08M Sell
31,400
-113,300
-78% -$3.89M 0.04% 466
2018
Q3
$6.8M Sell
144,700
-63,600
-31% -$2.99M 0.3% 88
2018
Q2
$7.03M Buy
208,300
+188,497
+952% +$6.36M 0.38% 72
2018
Q1
$536K Buy
+19,803
New +$536K 0.04% 459
2017
Q4
Sell
-68,739
Closed -$1.38M 829
2017
Q3
$1.38M Buy
+68,739
New +$1.38M 0.13% 210
2017
Q2
Sell
-46,232
Closed -$455K 723
2017
Q1
$455K Buy
+46,232
New +$455K 0.05% 386
2016
Q4
Sell
-54,605
Closed -$765K 635
2016
Q3
$765K Buy
+54,605
New +$765K 0.13% 216
2016
Q2
Sell
-11,211
Closed -$72K 514
2016
Q1
$72K Buy
+11,211
New +$72K 0.03% 291